Status:
COMPLETED
Electroacupuncture of Scalp Motor Area to Improve Post-Stroke Wrist Dyskinesia
Lead Sponsor:
Heilongjiang University of Chinese Medicine
Conditions:
Stroke Sequelae
Movement Disorders
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the clinical efficacy of electroacupuncture and manual acupuncture in stimulating the scalp motor area for treating post-stroke wrist dyskinesia and its i...
Detailed Description
Participants will be randomly divided into an electroacupuncture group and a manual acupuncture group according to a ratio of 1: 1. In the manual acupuncture group, participants will be needled in the...
Eligibility Criteria
Inclusion
- patients with upper limb movement disorders who meet the diagnostic criteria for stroke;
- 40 years old ≤ age ≤ 75 years old, gender is not limited;
- head MRI or CT scanning found responsible lesions;
- first onset of the disease, disease duration of 2 weeks to 6 months, stable condition, stable vital signs, conscious without unconsciousness;
- upper limb muscle strength on the affected side ≥ grade 3, wrist dorsiflexion muscle strength ≥ grade 2, wrist flexion muscle strength ≥ grade 2;
- no serious cardiac, pulmonary, or renal impairment;
- voluntarily participate in this study and sign the informed consent form.
Exclusion
- a previous history of stroke or other brain disease;
- with severe mental retardation and/or severe aphasia that interferes with communication;
- with severe cardiac, pulmonary, and renal impairment in an unstable condition;
- inability to autonomously perform wrist flexion and extension movements on the hemiplegic side;
- neurological or musculoskeletal diseases affecting the recovery of limb function before the onset of the disease, with pre-existing abnormalities in bilateral wrist movements;
- allergy to adhesive tape, solid gel, etc.; bleeding tendency, acute suppurative inflammation, combined ulcers, infections, scars and tumors at acupuncture points and nearby areas; installation of pacemakers;
- transient ischemic attack, rebleeding after infarction, bilateral cerebral infarction, brain stem infarction, excessive cerebral hemorrhage or cranial defect;
- history of needle fainting or fear of needling.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06208059
Start Date
July 1 2021
End Date
January 1 2023
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China, 150040